Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema
Recruiting
Observational Study
Lipedema
Hypermobility Syndrome (Disorder)
Pes Planus
Joint Hypermobility
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Female
- Study type
- Observational
- Participants needed
- 32 (estimated)
- Sponsor
- Marmara University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Lipedema is a chronic adipose tissue disorder that commonly leads to joint laxity, hypermobility, and functional limitations, yet its impact on foot morphology has not been systematically examined. This case-control study aims to investigate whether patients with lipedema exhibit a higher prevalence of generalized joint hypermobility and foot structural abnormalities-specifically pes planus-compar…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
General Inclusion Criteria (Apply to All Participants)
* Female participants
* Age 18 years or older
* Able to read and write (literacy requirement)
* Availability of bilateral lateral foot radiographs obtained within the past 1 year in the hospital PACS system
* Willing and able to provide written…
Contacts